​​​Un paso hacia el aprovechamiento de la energía limpia del agua de lluvia  | Newswise

​​​Un paso hacia el aprovechamiento de la energía limpia del agua de lluvia | Newswise

Newswise — Cuando dos materiales hacen contacto, las cargas en sus superficies reciben un pequeño empujón. Así es como el frotamiento de un globo sobre la piel genera electricidad estática. Del mismo modo, el agua que fluye sobre algunas superficies puede​​​​ ganar o perder carga. Ahora, investigadores que publican un artículo en ACS Central Science…

Read More
Compound Harnesses Cannabis’ Pain-Relieving Properties Without Side Effects | Newswise

Compound Harnesses Cannabis’ Pain-Relieving Properties Without Side Effects | Newswise

Newswise — Treatment for chronic pain still relies heavily on opioids. While effective, they are highly addictive and potentially deadly if misused. In the quest to develop a safe, effective alternative to opioids, researchers at Washington University School of Medicine in St. Louis and Stanford University have developed a compound that mimics a natural molecule found…

Read More
Study Finds Nearly Five-Fold Increase in Hospitalizations for Common Cause of Stroke | Newswise

Re-Purposed FDA-Approved Drug Could Help Treat High-Grade Glioma | Newswise

Newswise — High-grade glioma, an aggressive form of pediatric and adult brain cancer, is challenging to treat given the tumor location, incidence of recurrence and difficulty for drugs to cross the blood-brain barrier. Researchers from the University of Michigan, Dana Farber Cancer Institute and the Medical University of Vienna established a collaborative team to uncover…

Read More
New Technique Reveals How the Same Mutations Give Rise to Very Different Types of Leukaemia | Newswise

New Technique Reveals How the Same Mutations Give Rise to Very Different Types of Leukaemia | Newswise

Newswise — Barcelona, 25 February 2025 – Myeloid leukaemias are among the most aggressive blood cancers and have low survival rates. Today, leukaemia patients undergo genetic analysis to identify mutations and select the most appropriate treatment. However, even among patients with the same mutation, disease progression and response to therapy can vary significantly. A study…

Read More
Paxlovid’s Impact on Hospitalization and Death in COVID-Vaccinated Older Adults Far Weaker Than Previously Thought | Newswise

Paxlovid’s Impact on Hospitalization and Death in COVID-Vaccinated Older Adults Far Weaker Than Previously Thought | Newswise

Newswise — Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research.  The study questions the assumption that Paxlovid’s effectiveness in reducing COVID-19 hospitalizations and deaths in unvaccinated adults also applies to vaccinated adults. Pfizer’s 2022 clinical trial found reduced COVID-19 hospitalization in unvaccinated middle-aged adults; while…

Read More